The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Single point of entry to the European precision cancer medicine trial network PRIME-ROSE.
 
Kjetil Tasken
Stock and Other Ownership Interests - Ledidi; Serca Pharmaceuticals
Consulting or Advisory Role - Serca Pharmaceuticals
Research Funding - AstraZeneca (Inst); Illumina (Inst); Incyte (Inst); Lilly (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Stock and Stock options, and royalty agreement through Oslo University Hospital / University of Oslo Tech Transfer Office Inven2 AS.
Travel, Accommodations, Expenses - Roche
 
Gro Live Fagereng
Research Funding - AstraZeneca (Inst); Illumina (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Roche
 
Edvard Abel
No Relationships to Disclose
 
Edita Baltruskeviciene
No Relationships to Disclose
 
Katarina Steen Carlsson
No Relationships to Disclose
 
Ragnhild Sørum Falk
No Relationships to Disclose
 
Aslaug Helland
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Illumina (Inst); InCyte (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Roche (Inst); Ultimovacs (Inst)
 
Katriina Johanna Jalkanen
Employment - Terveystalo (I)
Stock and Other Ownership Interests - Faron Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - Bayer; Lilly; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Matthew G. Krebs
Honoraria - Roche
Consulting or Advisory Role - Achilles Therapeutics; Bayer; Guardant Health; Janssen; OM Pharma; Roche; Seagen
Speakers' Bureau - Janssen; Roche
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BerGenBio; BerGenBio; Immutep
 
Ulrik Niels Lassen
No Relationships to Disclose
 
Maeve Aine Lowery
Consulting or Advisory Role - AstraZeneca; Roche/Genentech; SERVIER
Research Funding - Astellas Pharma (Inst); Basilea (Inst); Exelixis (Inst); Genuity Science (Inst); Legend Biotech (Inst); MSD (Inst); Zymeworks (Inst)
 
Kristiina Ojamaa
No Relationships to Disclose
 
Julio Oliveira
Consulting or Advisory Role - GlaxoSmithKline; Novartis; Roche
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen Oncology; Novartis
 
Kristoffer Staal Rohrberg
Honoraria - MSD; MSD
Consulting or Advisory Role - Abbvie; Genmab
Research Funding - Alligator Bioscience (Inst); AstraZeneca (Inst); Bayer (Inst); Bioinvent (Inst); BioNTech SE (Inst); Bristol-Myers Squibb (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Loxo (Inst); Merus (Inst); MonTa Biosciences (Inst); MSD (Inst); Navire (Inst); Novartis (Inst); Orion Clinical (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Repare Therapeutics (Inst); Roche/Genentech (Inst); Symphogen (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst)
 
Bettina Ryll
Consulting or Advisory Role - BMS GmbH & Co. KG; Clinigen Healthcare; MSD Oncology; Novartis; Pierre Fabre; Roche
Other Relationship - BMS GmbH & Co. KG (Inst); MSD Oncology (Inst); Novartis (Inst)
 
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani
No Relationships to Disclose
 
Henk M.W. Verheul
No Relationships to Disclose
 
Loic Verlingue
Leadership - Resolved
Consulting or Advisory Role - Adaptherapy
Research Funding - Bristol-Myers Squibb
 
Emile E. Voest
Leadership - Mosaic Therapeutics; Sanofi
Stock and Other Ownership Interests - Mosaic Therapeutics; Sanofi
Consulting or Advisory Role - Biogeneration Ventures; InteRNA
Research Funding - astrazeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst)
 
Hans Gelderblom
Research Funding - AmMax Bio (Inst); Deciphera (Inst); Ipsen (Inst); Novartis (Inst)